Request a Type B meeting with the FDA to discuss AMT-130 study design approaches
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 2 Mar 2026
- Due
- 30 Jun 2026
- Delivered
- June 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“plans to request a Type B meeting in the second quarter of 2026 to further discuss potential study design approaches.”
What we found
Evidence strength A What the grades mean
The company held a Type B meeting with the FDA in June 2026, fulfilling its commitment to request and hold the meeting within the second quarter of 2026.
-
A uniQure N.V. 10-Q filed 2026-07-29
“In June 2026, we held a Type B meeting with the FDA.” ✓ confirmed on the page
Market reaction: the shares moved +18.2% against the S&P 500 over the three sessions around the disclosure (28 Jul 2026 to 31 Jul 2026). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Regulatory other
- Indicative materiality
- Medium rules
- Action
- Request
- Deliverable
- Type B meeting with FDA
- Where
- United States
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
- Conditional
- Yes: subject to FDA scheduling
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you uniQure N.V.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2026-QURE-001932 · Corrections policy